Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07689448

Preoperative Versus Postoperative Interscalene Block in Arthroscopic Rotator Cuff Repair

This study is evaluating whether the timing of an interscalene nerve block affects pain control and recovery after arthroscopic rotator cuff repair surgery.

An interscalene block is commonly used to reduce pain after shoulder surgery. However, it is not known whether administering the block before surgery or after surgery provides better outcomes. Participants undergoing arthroscopic rotator cuff repair are assigned to receive the interscalene block either before the surgical incision or after completion of the procedure.

The study compares postoperative pain levels, opioid medication use, length of hospital stay, and ultrasound imaging quality during block administration between the two groups. Functional recovery is also assessed using patient-reported outcome measures during follow-up.

The investigators hypothesize that administration of the interscalene block before surgery may provide superior early pain control and reduce postoperative opioid requirements while maintaining similar functional outcomes compared with administration after surgery.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Postoperative pain remains a major challenge following arthroscopic rotator cuff repair despite advances in multimodal analgesia protocols. Inadequate pain control may delay rehabilitation, increase opioid consumption, prolong hospitalization, and negatively affect patient satisfaction. Ultrasound-guided interscalene block has become a cornerstone of perioperative pain management for shoulder surgery because of its proven analgesic efficacy and favorable safety profile.

Although interscalene block is routinely used in clinical practice, the optimal timing of administration remains controversial. Administration before surgical incision may provide preemptive analgesic effects by attenuating central sensitization and reducing nociceptive input during surgery. In contrast, administration after completion of surgery has been proposed as a strategy to extend the duration of postoperative analgesia. Existing literature provides limited and inconsistent evidence regarding the comparative clinical benefits of these approaches in patients undergoing arthroscopic rotator cuff repair.

This study was designed to evaluate the impact of interscalene block timing within a contemporary shoulder surgery pathway. In addition to its potential influence on perioperative analgesia, the timing of block administration may affect procedural workflow and ultrasound visualization of relevant anatomical structures. Improved understanding of these factors may contribute to optimization of perioperative management strategies and support evidence-based recommendations for regional anesthesia practices in arthroscopic shoulder surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older.
  • Patients undergoing primary arthroscopic rotator cuff repair.
  • Presence of a repairable small-, medium-, or large-sized rotator cuff tear confirmed by clinical and imaging evaluation.
  • Receipt of an ultrasound-guided interscalene nerve block as part of perioperative pain management.
  • Ability to provide informed consent and comply with study follow-up requirements.

Exclusion criteria

  • Irreparable rotator cuff tears.
  • Partial-thickness rotator cuff tears not requiring repair.
  • Revision rotator cuff repair procedures.
  • Concomitant shoulder procedures that could substantially influence postoperative pain or functional outcomes (e.g., shoulder arthroplasty, fracture fixation).
  • Previous surgery on the affected shoulder.
  • Contraindications to interscalene nerve block, including local anesthetic allergy, infection at the injection site, or severe neurologic disease affecting the brachial plexus.
  • Chronic opioid use or opioid dependence before surgery.
  • Inability to complete study questionnaires or follow the postoperative rehabilitation protocol.
  • Missing baseline or follow-up data required for outcome assessment.

Treatment and study plan

Primary outcomes

  1. Early Postoperative Pain Intensity

    Time frame: Pre-procedure, postoperative 6th, 12th, 24th hours

    Patients' postoperative pain intensity measured using the Visual Analog Scale (VAS) following arthroscopic rotator cuff repair. Pain scores will be compared between pre-procedure and post-procedure interscalene block groups. The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse pain intensity.

Secondary outcomes

  1. Postoperative Opioid Consumption

    Time frame: 24 hours after surgery

    Total opioid consumption recorded during the first postoperative 24 hours.

  2. Patient-Controlled Analgesia Usage

    Time frame: 24 hours after surgery

    Number of patient-controlled analgesia (PCA) bolus demands during the postoperative period.

  3. Duration of hospitalization following arthroscopic rotator cuff repair.

    Time frame: From surgery until hospital discharge

    Duration of hospitalization following arthroscopic rotator cuff repair.

  4. Ultrasound Image Quality During Interscalene Block Administration

    Time frame: At the time of interscalene block administration

    Quality of ultrasound visualization of the interscalene region assessed by the performing anesthesiologist using a 5-point Likert scale.

  5. Oxford Shoulder Score

    Time frame: Baseline, 3 months, and 6 months after surgery

    Functional shoulder outcome assessed using the Oxford Shoulder Score questionnaire. The Oxford Shoulder Score ranges from 0 to 48, with higher scores indicating better shoulder function.

  6. Disabilities of the Arm, Shoulder and Hand (DASH) Score

    Time frame: Baseline, 3 months, and 6 months after surgery

    Upper extremity functional outcome assessed using the DASH questionnaire. The score ranges from 0 to 100, with higher scores indicating greater disability and worse upper extremity function.

Study contacts

Contact information is provided by the study sponsor or research team.

Kaya Turan, MD, FEBOT, Assoc Prof.

CONTACT

[email protected]

+905332937927

Sponsors and collaborators

Lead sponsor

Istinye University

Other

Registry information

Official study title

Pre-Procedure Versus Post-Procedure Administration of Interscalene Block in Arthroscopic Rotator Cuff Repair: Effects on Early Pain Control and Functional Outcomes

Acronym: ISB-ARCR

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 8, 2026
Registry last updated
Jul 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.